These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 19778001

  • 1. Dissecting the inhibition mechanism of cytosolic versus transmembrane carbonic anhydrases by ESR.
    Ciani L, Cecchi A, Temperini C, Supuran CT, Ristori S.
    J Phys Chem B; 2009 Oct 22; 113(42):13998-4005. PubMed ID: 19778001
    [Abstract] [Full Text] [Related]

  • 2. Carbonic anhydrase inhibitors: design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes.
    Cecchi A, Ciani L, Winum JY, Montero JL, Scozzafava A, Ristori S, Supuran CT.
    Bioorg Med Chem Lett; 2008 Jun 15; 18(12):3475-80. PubMed ID: 18513964
    [Abstract] [Full Text] [Related]

  • 3. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
    Leitans J, Sprudza A, Tanc M, Vozny I, Zalubovskis R, Tars K, Supuran CT.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5130-8. PubMed ID: 23859774
    [Abstract] [Full Text] [Related]

  • 4. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L, Fasolis G, Vullo D, Chohan ZH, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3096-101. PubMed ID: 15908204
    [Abstract] [Full Text] [Related]

  • 5. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3102-8. PubMed ID: 15905091
    [Abstract] [Full Text] [Related]

  • 6. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R, Agnello S, Ferro S, De Luca L, Vullo D, Brynda J, Mader P, Supuran CT, Chimirri A.
    J Med Chem; 2010 Mar 25; 53(6):2401-8. PubMed ID: 20170095
    [Abstract] [Full Text] [Related]

  • 7. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX.
    Alterio V, Vitale RM, Monti SM, Pedone C, Scozzafava A, Cecchi A, De Simone G, Supuran CT.
    J Am Chem Soc; 2006 Jun 28; 128(25):8329-35. PubMed ID: 16787097
    [Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
    Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Nov 01; 14(21):5427-33. PubMed ID: 15454239
    [Abstract] [Full Text] [Related]

  • 9. Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.
    Knaus EE, Innocenti A, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2011 Oct 01; 21(19):5892-6. PubMed ID: 21852133
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.
    Akdemir A, Güzel-Akdemir O, Scozzafava A, Capasso C, Supuran CT.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5228-32. PubMed ID: 23842519
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
    Sarikaya B, Ceruso M, Carta F, Supuran CT.
    Bioorg Med Chem; 2014 Nov 01; 22(21):5883-90. PubMed ID: 25267005
    [Abstract] [Full Text] [Related]

  • 12. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
    Pinard MA, Boone CD, Rife BD, Supuran CT, McKenna R.
    Bioorg Med Chem; 2013 Nov 15; 21(22):7210-5. PubMed ID: 24090602
    [Abstract] [Full Text] [Related]

  • 13. Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII.
    Saluja AK, Tiwari M, Vullo D, Supuran CT.
    Bioorg Med Chem Lett; 2014 Mar 01; 24(5):1310-4. PubMed ID: 24507918
    [Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides.
    Franchi M, Vullo D, Gallori E, Pastorek J, Russo A, Scozzafava A, Pastorekova S, Supuran CT.
    J Enzyme Inhib Med Chem; 2003 Aug 01; 18(4):333-8. PubMed ID: 14567548
    [Abstract] [Full Text] [Related]

  • 15. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B, Sławiński J, Pogorzelska A, Chojnacki J, Vullo D, Supuran CT.
    Eur J Med Chem; 2014 Jan 01; 71():135-47. PubMed ID: 24291567
    [Abstract] [Full Text] [Related]

  • 16. Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII.
    D'Ambrosio K, Vitale RM, Dogné JM, Masereel B, Innocenti A, Scozzafava A, De Simone G, Supuran CT.
    J Med Chem; 2008 Jun 12; 51(11):3230-7. PubMed ID: 18481843
    [Abstract] [Full Text] [Related]

  • 17. o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII.
    Güzel-Akdemir Ö, Akdemir A, Isik S, Vullo D, Supuran CT.
    Bioorg Med Chem; 2013 Mar 15; 21(6):1386-91. PubMed ID: 23352754
    [Abstract] [Full Text] [Related]

  • 18. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
    Winum JY, Dogné JM, Casini A, de Leval X, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.
    J Med Chem; 2005 Mar 24; 48(6):2121-5. PubMed ID: 15771455
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties.
    Alafeefy AM, Abdel-Aziz HA, Vullo D, Al-Tamimi AM, Awaad AS, Mohamed MA, Capasso C, Supuran CT.
    J Enzyme Inhib Med Chem; 2015 Feb 24; 30(1):52-6. PubMed ID: 24666294
    [Abstract] [Full Text] [Related]

  • 20. Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
    Ibrahim DA, Lasheen DS, Zaky MY, Ibrahim AW, Vullo D, Ceruso M, Supuran CT, Abou El Ella DA.
    Bioorg Med Chem; 2015 Aug 01; 23(15):4989-4999. PubMed ID: 26048024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.